NAIMIT Annual Meeting – 7 November 2011 – Leiden, The Netherlands

Posted on | September 2, 2011 | No Comments

Program

NAIMIT Annual Meeting – 7 November 2011 – Leiden, The Netherlands

Location:

Kasteel Oud-Poelgeest
Poelgeesterweg 1, 2341 NM Oegstgeest
, Leiden, The Netherlands

10.30 – 11.00 Arrival and welcome coffee

11.00 – 11.35 Jay Skyler – State of the art lecture on Clinical Prevention and Intervention Studies in Type 1 Diabetes

11.35 – 12.00 State of the Moment on NAIMIT – Chantal Mathieu

12.00 – 13.00 Lunch break

13.00 – 13.45 WP1 – Re-educating antigen-presenting cells
Introduction by WPL Bart Roep
Bart Roep: Tolerogenic Dendritic Cell Therapy
(25min talk + discussion)

13.45 – 14.30 WP2 – Restoring the T-cell balance
Introduction by WPL Mark Peakman
Mark Peakman: Towards T-cell tolerance
(25min talk + discussion)

14.30 – 14.50 Ezio Bonifacio: Update on FP7– DIAprepp

14.50 – 15.35 WP3 – TCR-directed immunotherapy
Introduction by WPL Chantal Mathieu
Rebecca Ashfield: ImmTAC technology applied to Cancer and Diabetes
(25min talk + discussion)

15.35 – 15.50 coffee break

15.50 – 16.35 WP4 – Mucosal intervention for tolerance restoration
Introduction by WPL Francesco Dotta
Pieter Rottiers: Mucosal tolerance induction with genetically engineered Lactococcus lactis
(25min talk + discussion)

16.35 – 16.55 Mikael Knip: DIABIMMUNE: Testing the hygiene hypothesis in type 1
diabetes and other immune-mediated diseases

16.55 – 17.40 WP5 – Beta-cell protection and restoration: dialogue with the immune
system. Introduction by WPL Decio Eizirik
Decio Eizirik: The beta-cell, more than a target in type 1 diabetes
(25min talk + discussion)

17.40 – 18.25 WP6 – Pharmacogenetics: towards individualised therapies.
Introduction by WPL Klaus Badenhoop
John Todd: Understanding genes- towards personalized medicine
(25min talk + discussion)

Registration is free, but please send an e-mail to
Lut.overbergh@med.kuleuven.be to confirm your participation before 1st of November

Comments